tradingkey.logo

Avantor Inc

AVTR

11.365USD

-2.075-15.44%
Fechamento 08/01, 16:00ETCotações atrasadas em 15 min
7.75BValor de mercado
10.82P/L TTM

Avantor Inc

11.365

-2.075-15.44%
Mais detalhes de Avantor Inc Empresa
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Informações da empresa
Código da empresaAVTR
Nome da EmpresaAvantor Inc
Data de listagemMay 17, 2019
Fundado em2017
CEOMr. Michael Stubblefield
Número de funcionários13500
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 17
Endereço- -
Cidade- -
Bolsa de valoresNYSE Consolidated
País- -
Código postal- -
Telefone- -
Site- -
Código da empresaAVTR
Data de listagemMay 17, 2019
Fundado em2017
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael Stubblefield
Mr. Michael Stubblefield
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.78M
-1.11%
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
201.96K
+416.65%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.74K
+246.29%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
140.58K
+76.82%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Dr. Michael E. Severino, M.D.
Dr. Michael E. Severino, M.D.
Independent Director
Independent Director
52.07K
+48.89%
Ms. Lan Kang
Ms. Lan Kang
Independent Director
Independent Director
43.84K
+63.95%
Ms. Kitty Sahin
Ms. Kitty Sahin
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
42.27K
-8.51%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Independent Director
Independent Director
39.83K
+75.24%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael Stubblefield
Mr. Michael Stubblefield
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.78M
-1.11%
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
201.96K
+416.65%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.74K
+246.29%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
140.58K
+76.82%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Proprietary materials & consumables
829.70M
52.47%
Third party materials & consumables
751.70M
47.53%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Proprietary materials & consumables
829.70M
52.47%
Third party materials & consumables
751.70M
47.53%
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Dodge & Cox
14.71%
The Vanguard Group, Inc.
9.48%
BlackRock Institutional Trust Company, N.A.
8.22%
T. Rowe Price Investment Management, Inc.
6.16%
Barrow Hanley Global Investors
4.44%
Other
56.98%
Investidores
Investidores
Proporção
Dodge & Cox
14.71%
The Vanguard Group, Inc.
9.48%
BlackRock Institutional Trust Company, N.A.
8.22%
T. Rowe Price Investment Management, Inc.
6.16%
Barrow Hanley Global Investors
4.44%
Other
56.98%
Tipos de investidores
Investidores
Proporção
Investment Advisor
53.11%
Investment Advisor/Hedge Fund
37.65%
Hedge Fund
2.48%
Pension Fund
2.36%
Private Equity
2.06%
Research Firm
1.61%
Bank and Trust
1.42%
Family Office
1.41%
Individual Investor
1.37%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
1129
699.68M
102.68%
-68.06M
2025Q1
1158
711.07M
104.35%
-68.24M
2024Q4
1156
702.95M
103.24%
-73.39M
2024Q3
1145
700.88M
103.10%
-38.62M
2024Q2
1147
666.63M
98.14%
-52.63M
2024Q1
1136
657.58M
96.83%
-81.17M
2023Q4
1152
657.17M
97.18%
-48.15M
2023Q3
1143
643.33M
95.20%
-49.55M
2023Q2
1149
625.74M
92.71%
-61.95M
2023Q1
1138
629.07M
93.23%
-29.97M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dodge & Cox
100.26M
14.71%
+1.12M
+1.13%
Mar 31, 2025
The Vanguard Group, Inc.
64.63M
9.48%
+956.59K
+1.50%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
56.00M
8.22%
+599.07K
+1.08%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
41.97M
6.16%
+608.81K
+1.47%
Mar 31, 2025
Barrow Hanley Global Investors
30.26M
4.44%
-270.10K
-0.88%
Mar 31, 2025
State Street Global Advisors (US)
23.60M
3.46%
+290.54K
+1.25%
Mar 31, 2025
Janus Henderson Investors
18.71M
2.75%
+571.10K
+3.15%
Mar 31, 2025
1832 Asset Management L.P.
18.13M
2.66%
+8.58M
+89.84%
Mar 31, 2025
UBS Financial Services, Inc.
16.26M
2.39%
+12.12M
+292.80%
Mar 31, 2025
Manulife Investment Management (North America) Limited
14.03M
2.06%
+4.88M
+53.25%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: dom, 6 de jul
Atualizado em: dom, 6 de jul
Nome
Proporção
Otter Creek Focus Strategy ETF
3.3%
First Trust Health Care Alphadex Fund
1.49%
John Hancock Fundamental All Cap Core ETF
1.24%
BNY Mellon Women's Opportunities ETF
0.95%
Amplify AI Powered Equity ETF
0.69%
Vanguard S&P Mid-Cap 400 Value Index Fund
0.68%
SPDR S&P 400 Mid Cap Value ETF
0.68%
First Trust Large Cap Value Alphadex Fund
0.59%
Pacer Trendpilot US Mid Cap ETF
0.39%
First Trust Large Cap Core Alphadex Fund
0.36%
Ver Mais
Otter Creek Focus Strategy ETF
Proporção3.3%
First Trust Health Care Alphadex Fund
Proporção1.49%
John Hancock Fundamental All Cap Core ETF
Proporção1.24%
BNY Mellon Women's Opportunities ETF
Proporção0.95%
Amplify AI Powered Equity ETF
Proporção0.69%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proporção0.68%
SPDR S&P 400 Mid Cap Value ETF
Proporção0.68%
First Trust Large Cap Value Alphadex Fund
Proporção0.59%
Pacer Trendpilot US Mid Cap ETF
Proporção0.39%
First Trust Large Cap Core Alphadex Fund
Proporção0.36%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI